Warner Chilcott Defends Dismissal Of Doryx Case In 3rd Circ.
Warner Chilcott PLC on Tuesday told the Third Circuit that it didn't have the market power to block generic competition for its acne medication Doryx when it pulled the capsules off...To view the full article, register now.
Already a subscriber? Click here to view full article